Kryczka, Wieslaw

Publishing since 1998 (Senior)

Has published 26 publications in 12 years

Number of publications published per year by Kryczka, Wieslaw. (Source : PubMed)

Distribution of publications types for Kryczka, Wieslaw. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Kukla M, Zwirska-Korczala K, Gabriel A, Waluga M, Warakomska I, Szczygiel B, Berdowska A, Mazur W, Wozniak-Grygiel E, Kryczka W. Chemerin, vaspin and insulin resistance in chronic hepatitis C.  J. Viral Hepat.  2009  
•  Kukla M, Zwirska-Korczala K, Gabriel A, Waluga M, Warakomska I, Berdowska A, Rybus-Kalinowska B, Kalinowski M, Janczewska-Kazek E, Woźniak-Grygiel E, Kryczka W. Visfatin serum levels in chronic hepatitis C patients.  J. Viral Hepat.  2009  
•  Flisiak R, Feinman SV, Jablkowski M, Horban A, Kryczka W, Pawlowska M, Heathcote JE, Mazzella G, Vandelli C, Nicolas-Métral V, Grosgurin P, Liz JS, Scalfaro P, Porchet H, Crabbé R. The cyclophilin inhibitor Debio 025 combined with PEG IFNalpha2a significantly reduces viral load in treatment-naïve hepatitis C patients.  Hepatology  2009;49;5  
•  Juszczyk J, Boroń-Kaczmarska A, Cianciara J, Flisiak R, Gładysz A, Halota W, Kryczka W, Małkowski P, Pawłowska M, Simon K. [Polish Experts Group on HBV. Therapeutic recommendations on 2008 year (antiretroviral treatment of chronic hepatitis B)]  Przegl Epidemiol  2008;62;2  
•  Kisiel E, Kryczka W. [Antiphospholipid antibodies with HCV infection. Innocent proteins or risk factor?]  Prz. Lek.  2007;64;7-8  
•  Zarebska-Michaluk D, Lebensztejn DM, Kryczka W. [Efficacy of combined antiviral therapy with interferon alfa and ribavirin in chronic hepatitis C patients with extrahepatic manifestations]  Przegl Epidemiol  2007;61;3  
•  Juszczyk J, Baka-Cwierz B, Beniowski M, Berak H, Bolewska B, Boroń-Kaczmarska A, Cianciara J, Cieśla A, Dziambor A, Gasiorowski J, Gietka A, Gliwińska E, Gładysz A, Gonciarz Z, Halota W, Horban A, Inglot M, Janas-Skulina U, Janczewska-Kazek E, Jaskowska J, Jurczyk K, Knysz B, Kryczka W, Kuydowicz J, Lakomy EA, Logiewa-Bazger B, Lyczak A, Mach T, Mazur W, Michalska Z, Modrzewska R, Nazzal K, Pabjan P, Piekarska A, Piszko P, Sikorska K, Szamotulska K, Sliwińska M, Swietek K, Tomasiewicz K, Topczewska-Staubach E, Trocha H, Wasilewski M, Wawrzynowicz-Syczewska M, Wrodycki W, Zarebska-Michaluk D, Zejc-Bajsarowicz M. [Pegylated interferon-alfa 2a with ribavirin in chronic viral hepatitis C (final report)]  Przegl Epidemiol  2005;59;3  
•  Kryczka W, Zarebska-Michaluk D, Chrapek M. [The impact of coexisting diseases on the course of chronic hepatitis C]  Przegl Epidemiol  2005;59;2  
•  Kryczka W, Chrapek M, Zarebska-Michaluk D. [Assessment of the usefulness of combination of selected clinical and demographic parameters in prediction of the severity of liver fibrosis in patients with chronic hepatitis C]  Przegl Epidemiol  2005;59;2  
•  Brojer E, Gronowska A, Medyńska J, Grabarczyk P, Mikulska M, Letowska M, Kryczka W, Gietka A. The hepatitis C virus genotype and subtype frequency in hepatitis C virus RNA-positive, hepatitis C virus antibody-negative blood donors identified in the nucleic acid test screening program in Poland.  Transfusion  2004;44;12  

[ See timeline ] [ See all publications ]